Spatio-temporal associations between deforestation and malaria incidence in Lao PDR
- University of California, San Francisco, United States
- University of Massachusetts-Amherst, United States
- University of California, Berkeley, United States
- Ministry of Health, Lao PDR, Lao People's Democratic Republic
Abstract
As countries in the Greater Mekong Sub-region (GMS) increasingly focus their malaria control and elimination efforts on reducing forest-related transmission, greater understanding of the relationship between deforestation and malaria incidence will be essential for programs to assess and meet their 2030 elimination goals. Leveraging village-level health facility surveillance data and forest cover data in a spatio-temporal modeling framework, we found evidence that deforestation is associated with short-term increases, but long-term decreases in confirmed malaria case incidence in Lao People's Democratic Republic (Lao PDR). We identified strong associations with deforestation measured within 30 km of villages but not with deforestation in the near (10 km) and immediate (1 km) vicinity. Results appear driven by deforestation in densely forested areas and were more pronounced for infections with Plasmodium falciparum (P. falciparum) than for Plasmodium vivax (P. vivax). These findings highlight the influence of forest activities on malaria transmission in the GMS.
Data availability
All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 2, 3, 4 and 5 and for Tables 1, 2 and 3.
-
Global Forest Change 2000-201810.1126/science.1244693.
Article and author information
Author details
Funding
Bill and Melinda Gates Foundation (OPP1116450)
- Francois Rerolle
- Emily Dantzer
- Andrew A Lover
- Bouasy Hongvanthong
- Hugh JW Sturrock
- Adam Bennett
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Reviewing Editor
- Ben S Cooper, Mahidol University, Thailand
Ethics
Human subjects: This study was approved by the National Ethics Committee for Health Research at the Lao Ministry of Health (Approval #2016-014; 8/22/2016) and by the UCSF ethical review board (Approvals #16-19649 and #17-22577). The informed consent process was consistent with local norms, and all study areas had a consultation meeting with, and approvals from, village elders. All participants provided informed written consent; caregivers provided consent for all children under 18, and all children aged 10 and above also provided consent directly. The study was conducted according to the ethical principles of the Declaration of Helsinki of October 2002.
Version history
- Received: March 16, 2020
- Accepted: February 19, 2021
- Accepted Manuscript published: March 9, 2021 (version 1)
- Version of Record published: April 6, 2021 (version 2)
Copyright
© 2021, Rerolle et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,464
- Page views
-
- 181
- Downloads
-
- 6
- Citations
Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Spatio-temporal associations between deforestation and malaria incidence in Lao PDR
eLife 10:e56974.
https://doi.org/10.7554/eLife.56974
Further reading
-
How does cutting down forests influence the spread of malaria?
-
- Epidemiology and Global Health
Paxlovid, a SARS-CoV-2 antiviral, not only prevents severe illness but also curtails viral shedding, lowering transmission risks from treated patients. By fitting a mathematical model of within-host Omicron viral dynamics to electronic health records data from 208 hospitalized patients in Hong Kong, we estimate that Paxlovid can inhibit over 90% of viral replication. However, its effectiveness critically depends on the timing of treatment. If treatment is initiated three days after symptoms first appear, we estimate a 17% chance of a post-treatment viral rebound and a 12% (95% CI: 0%-16%) reduction in overall infectiousness for non-rebound cases. Earlier treatment significantly elevates the risk of rebound without further reducing infectiousness, whereas starting beyond five days reduces its efficacy in curbing peak viral shedding. Among the 104 patients who received Paxlovid, 62% began treatment within an optimal three-to-five-day day window after symptoms appeared. Our findings indicate that broader global access to Paxlovid, coupled with appropriately timed treatment, can mitigate the severity and transmission of SARS-Cov-2.
